» Articles » PMID: 34375547

The Intrinsically Disorderly Story of Ki-67

Overview
Journal Open Biol
Date 2021 Aug 10
PMID 34375547
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Ki-67 is one of the most famous marker proteins used by histologists to identify proliferating cells. Indeed, over 30 000 articles referring to Ki-67 are listed on PubMed. Here, we review some of the current literature regarding the protein. Despite its clinical importance, our knowledge of the molecular biology and biochemistry of Ki-67 is far from complete, and its exact molecular function(s) remain enigmatic. Furthermore, reports describing Ki-67 function are often contradictory, and it has only recently become clear that this proliferation marker is itself dispensable for cell proliferation. We discuss the unusual organization of the protein and its mRNA and how they relate to various models for its function. In particular, we focus on ways in which the intrinsically disordered structure of Ki-67 might aid in the assembly of the still-mysterious mitotic chromosome periphery compartment by controlling liquid-liquid phase separation of nucleolar proteins and RNAs.

Citing Articles

High Ki67 expression, HER2 overexpression, and low progesterone receptor levels in high-grade DCIS: significant associations with clinical practice implications.

Schandiz H, Farkas L, Park D, Liu Y, Andersen S, Sauer T Front Oncol. 2025; 15:1467664.

PMID: 39959664 PMC: 11826238. DOI: 10.3389/fonc.2025.1467664.


Clinical significance of Ki-67 in patients with lung adenocarcinoma complicated by type 2 diabetes.

Chen K, Wang G, Hu J, Zhou Y, Ma H World J Diabetes. 2025; 16(2):98423.

PMID: 39959263 PMC: 11718486. DOI: 10.4239/wjd.v16.i2.98423.


Modulation of biological activities in adipose derived stem cells by histone deacetylation.

Abdallah S, Tabebi M, Qanadilo S, Ali N, Wang J, Darcy P Sci Rep. 2025; 15(1):3629.

PMID: 39880862 PMC: 11779964. DOI: 10.1038/s41598-024-84652-1.


KI-67 as a predictive indicator of papillary thyroid cancer in Iraqi patients.

Al-Timimi N, Baraaj A Probl Endokrinol (Mosk). 2025; 70(6):62-66.

PMID: 39868448 PMC: 11775681. DOI: 10.14341/probl13410.


Post-Translational Modifications of Proteins Orchestrate All Hallmarks of Cancer.

Bruno P, Arshad A, Gogu M, Waterman N, Flack R, Dunn K Life (Basel). 2025; 15(1).

PMID: 39860065 PMC: 11766951. DOI: 10.3390/life15010126.


References
1.
Goldman N, Yang Z . A codon-based model of nucleotide substitution for protein-coding DNA sequences. Mol Biol Evol. 1994; 11(5):725-36. DOI: 10.1093/oxfordjournals.molbev.a040153. View

2.
Halasova E, Adamkov M, Matakova T, Vybohova D, Antosova M, Janickova M . Expression of Ki-67, Bcl-2, Survivin and p53 Proteins in Patients with Pulmonary Carcinoma. Adv Exp Med Biol. 2012; 756:15-21. DOI: 10.1007/978-94-007-4549-0_3. View

3.
Ohta S, Bukowski-Wills J, Sanchez-Pulido L, de Lima Alves F, Wood L, Chen Z . The protein composition of mitotic chromosomes determined using multiclassifier combinatorial proteomics. Cell. 2010; 142(5):810-21. PMC: 2982257. DOI: 10.1016/j.cell.2010.07.047. View

4.
Gerdes J, STEIN H, Pileri S, Rivano M, Gobbi M, Ralfkiaer E . Prognostic relevance of tumour-cell growth fraction in malignant non-Hodgkin's lymphomas. Lancet. 1987; 2(8556):448-9. DOI: 10.1016/s0140-6736(87)90977-9. View

5.
Choong P, Akerman M, Willen H, Andersson C, Gustafson P, Baldetorp B . Prognostic value of Ki-67 expression in 182 soft tissue sarcomas. Proliferation--a marker of metastasis?. APMIS. 1994; 102(12):915-24. DOI: 10.1111/j.1699-0463.1994.tb05253.x. View